To Prime or Not to Prime - Is That Still a Question? A Comment on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents

Maria Lodefalk^{1

2}, Ola Nilsson^{1

3}

Affiliations

¹ Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden.
² University Health Care Research Center, Örebro University, Örebro, Sweden.
³ Division of Paediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.

Comment

Maria Lodefalk et al. Horm Res Paediatr. 2017.

. 2017;88(2):179-180.

doi: 10.1159/000475712. Epub 2017 May 15.

Maria Lodefalk^{1

2}, Ola Nilsson^{1

3}

¹ Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden.
² University Health Care Research Center, Örebro University, Örebro, Sweden.
³ Division of Paediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.

No abstract available

Comment on

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency.
Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH; Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Grimberg A, et al. Horm Res Paediatr. 2016;86(6):361-397. doi: 10.1159/000452150. Epub 2016 Nov 25. Horm Res Paediatr. 2016. PMID: 27884013